
It is understood that the health ministry’s expert committee which advises Drugs Controller General, recommended approval to Natco Pharma, Alembic, Emcure, Gufic and Lyka, subject to certain conditions.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2T9Nrrd
via
IFTTT
0 comments:
Post a Comment